01 2Chemische Fabrik Berg GmbH
02 3Excella GmbH & Co. KG
03 1Excella Gmbh & Co. KG
04 2Olon SpA
05 1Plantex Ltd
06 2Professional Compounding Centers of America dba PCCA
07 1Spectrum Laboratory Products, Inc.
01 1TAMOXIFEN CITRATE
02 7Tamoxifen Citrate
03 4Tamoxifen citrate
01 2Germany
02 1Israel
03 2Italy
04 4Luxembourg
05 1U.S.A
06 2United Kingdom
NDC Package Code : 65319-1051
Start Marketing Date : 2020-04-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65319-1151
Start Marketing Date : 2019-02-28
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 46014-1015
Start Marketing Date : 2000-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 46014-1180
Start Marketing Date : 2022-01-03
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 46014-1190
Start Marketing Date : 2022-01-03
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 46014-1200
Start Marketing Date : 2022-01-03
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 17337-0034
Start Marketing Date : 2012-12-05
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 17337-0035
Start Marketing Date : 2012-12-05
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 36974-0048
Start Marketing Date : 2019-09-12
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (100kg/100kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 49452-7571
Start Marketing Date : 1998-07-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
A Tamoxifen Citrate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Tamoxifen Citrate, including repackagers and relabelers. The FDA regulates Tamoxifen Citrate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Tamoxifen Citrate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Tamoxifen Citrate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Tamoxifen Citrate supplier is an individual or a company that provides Tamoxifen Citrate active pharmaceutical ingredient (API) or Tamoxifen Citrate finished formulations upon request. The Tamoxifen Citrate suppliers may include Tamoxifen Citrate API manufacturers, exporters, distributors and traders.
click here to find a list of Tamoxifen Citrate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Tamoxifen Citrate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Tamoxifen Citrate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Tamoxifen Citrate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Tamoxifen Citrate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Tamoxifen Citrate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Tamoxifen Citrate suppliers with NDC on PharmaCompass.
We have 6 companies offering Tamoxifen Citrate
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
